Levodopa/carbidopa/entacapone-induced acute Pisa syndrome in a Parkinson's disease patient

被引:25
|
作者
Solla, Paolo [1 ]
Cannas, Antonino [1 ]
Congia, Socrate [1 ]
Floris, Gianluca [1 ]
Aste, Rosa [1 ]
Tacconi, Paolo [1 ]
Marrosu, Maria Giovanna [1 ]
机构
[1] Univ Cagliari, Inst Neurol, Ctr Disordini Movimento, Dipartimento Sci Cardiovasc & Neurol,Sez Neurol, I-09124 Cagliari, Italy
关键词
Pisa syndrome; Parkinson's disease; Dystonia; Entacapone/levodopa/carbidopa combination;
D O I
10.1016/j.jns.2008.07.017
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Pisa syndrome (PS) is a dystonic lateroflexion of the trunk with a postural disturbance resembling the leaning tower of Pisa. Initially reported as a side effect related to antipsychotic therapy, this original dystonic Posture is also manifested in neurodegenerative disorders such as Alzheimer's disease and multiple system atrophy, or in rare idiopathic cases. Recent observations have described the onset of PS with subchronic course in patients affected by Parkinson's disease (PD). Here, we report on the acute development of PS in a parkinsonian patient during treatment with entacapone/levodopa/carbidopa combination. This case illustrates how, in contrast to previously well-known chronic/subchronic forms, this axial dystonic posture may occur in PD as an acute onset reversible type, related to levodopa treatment. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:154 / 156
页数:3
相关论文
共 50 条
  • [21] Levodopa-entacapone-carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease
    Othman, Mezin
    Bergquist, Filip
    Odin, Per
    Scharfenort, Monica
    Johansson, Anders
    Markaki, Ioanna
    Svenningsson, Per
    Dizdar, Nil
    Nyholm, Dag
    EUROPEAN JOURNAL OF NEUROLOGY, 2025, 32 (01)
  • [22] Entacapone improves the pharmacokinetic and therapeutic response of controlled release levodopa/carbidopa in Parkinson's patients
    Stocchi, F
    Barbato, L
    Nordera, G
    Bolner, A
    Caraceni, T
    JOURNAL OF NEURAL TRANSMISSION, 2004, 111 (02) : 173 - 180
  • [23] Use of the new levodopa agent Stalevo (levodopa/carbidopa/entacapone) in the treatment of Parkinson's disease in out-patient clinical practice (the START-M open trial)
    Boiko A.N.
    Batysheva T.T.
    Minaeva N.G.
    Babina L.A.
    Vdovichenko T.V.
    Zhuravleva E.Y.U.
    Shikhkerimov R.K.
    Malykhina E.A.
    Khozova A.A.
    Zaitsev K.A.
    Kostenko E.V.
    Neuroscience and Behavioral Physiology, 2008, 38 (9) : 933 - 936
  • [24] Quetiapine Relieved Pisa Syndrome in Patient With Parkinson Disease
    Zhao, Junwu
    Wang, Quan
    Sun, Hairong
    Liu, Xiaoxiao
    Leng, Bing
    Wang, Tong
    CLINICAL NEUROPHARMACOLOGY, 2020, 43 (06) : 171 - 174
  • [25] Pisa syndrome and scoliosis in Parkinson's disease
    Solla, Paolo
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2016, 151 : 143 - 144
  • [26] Pisa syndrome in Parkinson's disease: an electrophysiological and imaging study
    Tinazzi, Michele
    Juergenson, Ina
    Squintani, Giovanna
    Vattemi, Gaetano
    Montemezzi, Stefania
    Censi, Daniela
    Barone, Paolo
    Bovi, Tommaso
    Fasano, Alfonso
    JOURNAL OF NEUROLOGY, 2013, 260 (08) : 2138 - 2148
  • [27] Pisa syndrome in Parkinson’s disease: an electrophysiological and imaging study
    Michele Tinazzi
    Ina Juergenson
    Giovanna Squintani
    Gaetano Vattemi
    Stefania Montemezzi
    Daniela Censi
    Paolo Barone
    Tommaso Bovi
    Alfonso Fasano
    Journal of Neurology, 2013, 260 : 2138 - 2148
  • [28] Brasofensine treatment for Parkinson's disease in combination with levodopa/carbidopa
    Frackiewicz, EJ
    Jhee, SS
    Shiovitz, TM
    Webster, J
    Topham, C
    Dockens, RC
    Whigan, D
    Salazar, DE
    Cutler, NR
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (02) : 225 - 230
  • [29] A 4-Year Follow-Up of Levodopa-Entacapone-Carbidopa Intestinal Gel Treatment in Parkinson's Disease
    Othman, Mezin
    Nyholm, Dag
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (12): : 1609 - 1612
  • [30] Immediate Versus Delayed Switch From Levodopa/Carbidopa to Levodopa/Carbidopa/Entacapone: Effects on Motor Function and Quality of Life in Patients With Parkinson's Disease With End-of-Dose Wearing Off
    Lew, Mark F.
    Somogyi, Monique
    McCague, Kevin
    Welsh, Mickie
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2011, 121 (11) : 605 - 613